Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolina Schinke

Concepts (316)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
75
2024
2915
8.520
Why?
Hematopoietic Stem Cell Transplantation
9
2024
554
2.200
Why?
Antibodies, Bispecific
7
2024
70
2.070
Why?
B-Cell Maturation Antigen
8
2024
88
1.710
Why?
Bone Marrow
11
2024
351
1.390
Why?
Leukemia, Plasma Cell
2
2020
33
1.360
Why?
Neoplasms, Plasma Cell
3
2024
35
1.310
Why?
Paraproteinemias
2
2022
71
1.300
Why?
Humans
90
2024
49898
1.200
Why?
Immunotherapy, Adoptive
6
2024
158
1.200
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
111
1.170
Why?
Neoplasm, Residual
6
2022
156
1.150
Why?
Immunoglobulin Light Chains
2
2017
82
1.040
Why?
Transplantation, Autologous
10
2024
462
1.020
Why?
Myelodysplastic Syndromes
5
2016
79
0.910
Why?
Immunoconjugates
2
2022
38
0.890
Why?
Mutation
8
2022
1292
0.890
Why?
Antibodies, Monoclonal
6
2023
457
0.820
Why?
Leukemia, Myeloid, Acute
4
2019
179
0.800
Why?
Prognosis
16
2024
1956
0.770
Why?
Gene Expression Regulation, Neoplastic
9
2024
824
0.760
Why?
Health Personnel
1
2024
251
0.760
Why?
Gene Expression Profiling
10
2023
1028
0.750
Why?
Aged
24
2024
9447
0.740
Why?
Testis
1
2021
65
0.720
Why?
Tumor Microenvironment
5
2024
221
0.690
Why?
Hematopoietic Stem Cells
3
2019
182
0.680
Why?
Cell Proliferation
8
2023
986
0.650
Why?
Clonal Evolution
4
2024
56
0.640
Why?
Gene Expression
3
2018
612
0.630
Why?
Male
31
2024
25437
0.600
Why?
Middle Aged
23
2024
12285
0.600
Why?
Clinical Trials as Topic
6
2023
466
0.570
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
994
0.570
Why?
Signal Transduction
5
2024
1608
0.570
Why?
Translocation, Genetic
5
2021
263
0.560
Why?
Thoracic Neoplasms
1
2016
13
0.530
Why?
Plasmacytoma
1
2016
39
0.510
Why?
Receptors, Interleukin-8B
1
2015
4
0.500
Why?
Survival Analysis
8
2024
670
0.490
Why?
Adult
19
2024
13346
0.490
Why?
Interleukin-8
1
2015
85
0.480
Why?
Female
27
2024
26560
0.450
Why?
Plasma Cells
5
2023
221
0.450
Why?
Receptors, G-Protein-Coupled
2
2024
53
0.440
Why?
Antineoplastic Agents
7
2024
1175
0.430
Why?
Combined Modality Therapy
4
2024
638
0.420
Why?
Stem Cell Transplantation
4
2024
179
0.410
Why?
Fluorodeoxyglucose F18
5
2021
189
0.400
Why?
Neutropenia
2
2023
114
0.400
Why?
DNA Methylation
4
2020
544
0.390
Why?
Oncogene Proteins, Fusion
2
2018
59
0.380
Why?
Neoplasms, Second Primary
2
2024
74
0.380
Why?
Chromosomes, Human, Pair 1
3
2023
92
0.370
Why?
Polycomb Repressive Complex 2
2
2021
46
0.370
Why?
Neoplasm Recurrence, Local
7
2024
626
0.370
Why?
Positron-Emission Tomography
4
2022
286
0.370
Why?
Epigenesis, Genetic
4
2020
370
0.370
Why?
Evolution, Molecular
2
2021
97
0.360
Why?
Tretinoin
1
2010
53
0.340
Why?
Aged, 80 and over
8
2024
3136
0.340
Why?
Treatment Outcome
10
2024
5176
0.330
Why?
Risk Assessment
4
2024
1254
0.330
Why?
Immunoglobulin kappa-Chains
2
2021
20
0.320
Why?
Transcription Factors
3
2023
565
0.320
Why?
DNA-Binding Proteins
2
2021
424
0.290
Why?
Neoplasm Proteins
3
2020
321
0.290
Why?
Cell Line, Tumor
6
2024
1388
0.290
Why?
Melanoma
1
2010
281
0.280
Why?
Transcriptome
2
2020
312
0.280
Why?
Disease Progression
7
2023
820
0.260
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2024
84
0.260
Why?
Biopsy
2
2018
591
0.250
Why?
Radiopharmaceuticals
3
2021
204
0.240
Why?
Skin Neoplasms
1
2010
487
0.240
Why?
Dexamethasone
3
2024
424
0.240
Why?
T-Lymphocytes
5
2024
328
0.230
Why?
Chemokine CXCL12
1
2024
30
0.230
Why?
Kaplan-Meier Estimate
3
2021
463
0.230
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2024
2
0.230
Why?
Antigens, CD19
1
2024
26
0.230
Why?
Mutation Rate
2
2021
36
0.220
Why?
Genome-Wide Association Study
1
2024
163
0.220
Why?
Myeloproliferative Disorders
1
2023
26
0.220
Why?
Cell Cycle
2
2021
226
0.220
Why?
Neoplasm Staging
2
2024
749
0.210
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.200
Why?
Drug Resistance, Neoplasm
1
2024
314
0.200
Why?
Genomics
2
2023
284
0.200
Why?
Qualitative Research
1
2024
336
0.200
Why?
Osteolysis
1
2022
75
0.200
Why?
Drug Approval
1
2022
47
0.200
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.200
Why?
Lymphoma, B-Cell
1
2022
61
0.190
Why?
Polymorphism, Single Nucleotide
1
2024
482
0.190
Why?
Hematologic Diseases
1
2021
21
0.190
Why?
Bone Marrow Transplantation
1
2022
112
0.190
Why?
Epigenomics
1
2021
67
0.190
Why?
Patient Participation
1
2022
67
0.190
Why?
Genetic Predisposition to Disease
1
2024
507
0.190
Why?
Risk Factors
8
2024
3604
0.190
Why?
Abnormal Karyotype
1
2021
6
0.190
Why?
Chromosome Deletion
2
2023
138
0.190
Why?
Myeloma Proteins
1
2021
24
0.180
Why?
Drug Design
2
2013
119
0.180
Why?
Immunoglobulin A
1
2021
45
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
123
0.180
Why?
Communicable Diseases
1
2021
52
0.180
Why?
Antibodies, Monoclonal, Humanized
1
2022
223
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Hematologic Neoplasms
1
2022
98
0.180
Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.180
Why?
Salvage Therapy
1
2021
136
0.180
Why?
Practice Guidelines as Topic
1
2023
458
0.180
Why?
Immunoglobulin G
1
2021
184
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Bone Resorption
1
2022
297
0.170
Why?
Neoplasm Invasiveness
1
2021
268
0.170
Why?
Bone Diseases
1
2021
97
0.170
Why?
Recurrence
5
2024
658
0.170
Why?
Gene Amplification
1
2019
57
0.170
Why?
Atrial Fibrillation
1
2022
182
0.170
Why?
Chromosomal Instability
1
2019
16
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
United States
3
2024
4878
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Healthcare Disparities
1
2022
279
0.160
Why?
Mice
5
2024
5658
0.160
Why?
Comorbidity
1
2021
610
0.160
Why?
Sulfonamides
1
2019
125
0.160
Why?
Models, Statistical
1
2020
225
0.160
Why?
Spleen
1
2019
170
0.150
Why?
Spinal Fractures
1
2018
37
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Bacteremia
1
2019
90
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Cell Differentiation
3
2022
649
0.150
Why?
Gene Rearrangement
1
2018
73
0.140
Why?
Disease-Free Survival
4
2019
450
0.140
Why?
Kidney Function Tests
1
2017
49
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.140
Why?
Glomerular Filtration Rate
1
2017
110
0.140
Why?
Calcification, Physiologic
1
2017
40
0.140
Why?
Survival Rate
4
2020
905
0.140
Why?
HIV Infections
1
2021
355
0.140
Why?
Pelvis
1
2017
66
0.140
Why?
Histoplasma
1
2016
26
0.140
Why?
Chromosome Aberrations
2
2023
295
0.140
Why?
CA-125 Antigen
1
2016
16
0.140
Why?
Receptor, TIE-2
1
2016
16
0.140
Why?
Animals
7
2024
13100
0.130
Why?
Retrospective Studies
6
2024
6123
0.130
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.130
Why?
Histoplasmosis
1
2016
49
0.130
Why?
Urea
1
2016
77
0.130
Why?
Indazoles
1
2016
44
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
96
0.130
Why?
Remission Induction
3
2024
205
0.130
Why?
Gastrointestinal Diseases
1
2016
128
0.130
Why?
Tumor Suppressor Protein p53
1
2017
213
0.130
Why?
Proteasome Inhibitors
1
2016
104
0.120
Why?
Immunologic Factors
1
2016
112
0.120
Why?
Cell Cycle Checkpoints
1
2015
30
0.120
Why?
Kidney Diseases
1
2017
211
0.120
Why?
Time Factors
2
2021
2891
0.120
Why?
Cluster Analysis
1
2015
233
0.120
Why?
Xenograft Model Antitumor Assays
1
2015
212
0.120
Why?
Myocardium
1
2017
443
0.120
Why?
Thrombopoiesis
1
2014
5
0.120
Why?
Hydrazines
1
2014
17
0.120
Why?
Benzoates
1
2014
22
0.110
Why?
Neoplastic Stem Cells
1
2015
100
0.110
Why?
Immunotherapy
1
2016
235
0.110
Why?
Demography
2
2024
93
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Disease Models, Animal
2
2016
1411
0.110
Why?
Cross-Sectional Studies
3
2023
1573
0.110
Why?
Cell Survival
1
2015
590
0.110
Why?
Pyrazoles
1
2014
111
0.110
Why?
Chromosomes, Human, Pair 7
1
2012
29
0.100
Why?
Clone Cells
2
2023
78
0.100
Why?
Cardiovascular Diseases
1
2017
444
0.100
Why?
Chromatin
2
2024
137
0.100
Why?
STAT3 Transcription Factor
1
2012
80
0.100
Why?
Cell Transformation, Neoplastic
1
2013
181
0.100
Why?
Follow-Up Studies
3
2024
2175
0.100
Why?
Thalidomide
1
2014
374
0.100
Why?
Flow Cytometry
2
2012
470
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
256
0.090
Why?
Leukemia, Promyelocytic, Acute
1
2010
10
0.090
Why?
Luciferases
1
2010
50
0.090
Why?
Response Elements
1
2010
29
0.090
Why?
Gene Silencing
1
2010
114
0.090
Why?
Alleles
2
2021
251
0.090
Why?
Tumor Burden
2
2020
131
0.080
Why?
Transfection
1
2010
354
0.080
Why?
Recombinant Fusion Proteins
1
2010
186
0.080
Why?
Molecular Structure
1
2010
293
0.080
Why?
Histones
2
2021
295
0.080
Why?
Apoptosis
2
2014
1092
0.080
Why?
DNA Copy Number Variations
2
2021
108
0.080
Why?
Syndecan-1
2
2021
72
0.070
Why?
Case-Control Studies
2
2024
1128
0.070
Why?
Tumor Cells, Cultured
2
2020
462
0.070
Why?
Imaging, Three-Dimensional
2
2017
152
0.060
Why?
Gene Expression Regulation
1
2010
964
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Telomere
1
2024
36
0.060
Why?
Arkansas
2
2021
1987
0.060
Why?
Mitogen-Activated Protein Kinase Kinases
1
2024
32
0.060
Why?
Killer Cells, Natural
1
2024
107
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
124
0.060
Why?
Antibodies
1
2024
151
0.050
Why?
B-Lymphocytes
1
2024
175
0.050
Why?
Receptors, Antigen, T-Cell
1
2023
49
0.050
Why?
Cell Communication
1
2023
69
0.050
Why?
Neoplasms
1
2013
1233
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
47
0.050
Why?
Geography
1
2022
61
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Patient Selection
1
2023
254
0.050
Why?
Infant
1
2010
3572
0.050
Why?
United States Food and Drug Administration
1
2022
91
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Tomography, X-Ray Computed
2
2017
1150
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
103
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Pyrimidines
1
2022
192
0.050
Why?
Aneuploidy
1
2020
18
0.050
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.040
Why?
Genome, Human
1
2021
110
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Protein Kinase Inhibitors
1
2022
205
0.040
Why?
DNA, Neoplasm
1
2020
145
0.040
Why?
Health Status Disparities
1
2022
196
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
168
0.040
Why?
Osteoclasts
1
2022
424
0.040
Why?
Multivariate Analysis
1
2021
579
0.040
Why?
Computational Biology
1
2020
214
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
27
0.040
Why?
Pseudomonas Infections
1
2019
47
0.040
Why?
Syndrome
1
2019
237
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
550
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Protein-Tyrosine Kinases
1
2018
95
0.040
Why?
False Positive Reactions
1
2017
60
0.040
Why?
Bone and Bones
1
2021
473
0.040
Why?
Amino Acid Sequence
1
2018
579
0.030
Why?
Databases, Factual
1
2020
660
0.030
Why?
Itraconazole
1
2016
41
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
beta-Glucans
1
2016
23
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Angiopoietin-1
1
2016
16
0.030
Why?
Amphotericin B
1
2016
110
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Ileum
1
2016
86
0.030
Why?
NF-kappa B
1
2018
315
0.030
Why?
Intestinal Obstruction
1
2016
36
0.030
Why?
Glycolysis
1
2016
68
0.030
Why?
Colonoscopy
1
2016
96
0.030
Why?
Gene Knockdown Techniques
1
2016
106
0.030
Why?
Models, Genetic
1
2016
174
0.030
Why?
Genomic Instability
1
2016
91
0.030
Why?
Fever
1
2016
111
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
131
0.030
Why?
Staphylococcal Infections
1
2019
269
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Logistic Models
1
2018
895
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
139
0.030
Why?
Heart
1
2017
334
0.030
Why?
Proportional Hazards Models
1
2016
404
0.030
Why?
Algorithms
1
2018
613
0.030
Why?
Echocardiography
1
2017
381
0.030
Why?
Weight Loss
1
2016
241
0.030
Why?
Megakaryocyte Progenitor Cells
1
2014
1
0.030
Why?
Young Adult
1
2024
4029
0.030
Why?
Longitudinal Studies
1
2016
693
0.030
Why?
Antifungal Agents
1
2016
343
0.030
Why?
Models, Immunological
1
2013
8
0.030
Why?
Chemistry, Pharmaceutical
1
2013
33
0.030
Why?
Early Diagnosis
1
2013
87
0.030
Why?
Azacitidine
1
2012
34
0.030
Why?
Karyotyping
1
2012
82
0.030
Why?
Primary Cell Culture
1
2012
61
0.030
Why?
Cell Lineage
1
2012
83
0.030
Why?
Polymerase Chain Reaction
1
2013
456
0.020
Why?
Child
1
2024
6844
0.020
Why?
Antigens, CD
1
2012
215
0.020
Why?
Enzyme Inhibitors
1
2013
378
0.020
Why?
Magnetic Resonance Imaging
1
2017
1525
0.020
Why?
Cytokines
1
2013
607
0.020
Why?
Reproducibility of Results
1
2013
1182
0.020
Why?
Cohort Studies
1
2013
1403
0.020
Why?
Schinke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description